In the News

Daily Mail featured a study by Valter Longo on how individuals with Laron syndrome appear to be protected against heart disease. ‘It doesn’t mean that they are immune to these diseases, but people with Laron syndrome certainly seem to be very protected,’ said Longo. ‘This is how powerful this mutation seems to be.’

Earth.com featured a study by Valter Longo on how patients with Laron syndrome appear to have reduced heart disease risks.

SciTechDaily featured a study by Valter Longo on how patients with Laron syndrome appear to have reduced heart disease risks.

Longevity Technology featured a study by Valter Longo on how Laron syndrome patients appear to have less risk of heart disease. “These findings suggest that individuals with GHRD have normal or improved levels of cardiovascular disease risk factors compared to their relatives,” said Longo. “Although the population tested is small, together with studies in mice and other organisms this human data provide valuable insights into the health effects of growth hormone receptor deficiency and suggest that drugs or dietary interventions that cause similar effects could reduce disease incidence and possibly extend longevity.”

CNN featured a study co-led by Valter Longo that described how patients with Laron syndrome appear to be at reduced risk of heart attack and other illnesses. “We have shown in studies people with Laron have a very low incidence of cancer, diabetes and cognitive decline. Brain scans have shown they have more youthful brains — the equivalent of someone 20 years younger. I have yet to see a case of Alzheimer’s in this population,” Longo said. “It doesn’t mean that they are immune to these diseases, but people with Laron syndrome certainly seem to be very protected. … This is how powerful this mutation seems to be.” The story also appeared on CTV News (Canada).

Medical Xpress covered a study by Valter Longo that described how patients with Laron syndrome appear to have a reduced risk for heart attack.

Talker News featured a study by Valter Longo on how patients with Laron syndrome appear to have reduced heart disease risks. The story was republished widely, including by the Wilkes-Barre Citizens Voice, Mercury (Manhattan. KS), Tyler Morning Telegraph (TX), Tioga Publishing (PA), Bangor, ME Fox affiliate WFVX, and Yakima, WA NBC affiliate KNDO.

New Scientist featured a study by Valter Longo on how Laron syndrome patients appear to face fewer heart disease risks.

Nature featured a study by Valter Longo on how patients with Laron syndrome appear to face fewer heart disease risks. “In some sense, this was the most important of all studies,” Longo said. “It was the last piece missing in showing that they seem to be protected from all the major age-related diseases.”

PsyPost featured research coauthored by Em Arpawong on an analysis that showed individuals who had better cognitive ability as adolescents were less likely to develop dementia 60 years later.